119 related articles for article (PubMed ID: 13166555)
21. [A new anticoagulant: 3-(1-phenylpropyl)4-hydroxycoumarin; early clinical results].
VAN WIEN A; VEROFT R
Acta Clin Belg; 1953; 8(6):618-28. PubMed ID: 13137838
[No Abstract] [Full Text] [Related]
22. Clinical evaluation of acenocoumarin, a new 4-hydroxycoumarin anticoagulant.
SCHILLING FJ; KRUESI OR
Am J Med Sci; 1956 May; 231(5):558-63. PubMed ID: 13313541
[No Abstract] [Full Text] [Related]
23. [Mode of antibacterial activity of 3-acetyl-4-hydroxycoumarin and dehydroacetic acid. I].
UKITA T; EJIMA A
Yakugaku Zasshi; 1962 Dec; 82():1625-30. PubMed ID: 13995262
[No Abstract] [Full Text] [Related]
24. Comparison of the anticoagulant action of 3-(alpha-p-chlorphenyl-beta-acetylethyl)-4-hydroxycoumarin (coumachlor) and dicoumarol in chicks and rats.
DAM H; SØNDERGAARD E
Acta Pharmacol Toxicol (Copenh); 1953; 9(2):137-47. PubMed ID: 13079850
[No Abstract] [Full Text] [Related]
25. [Coagulatory and histomorphological modifications induced by 3-(1-phenyl-propyl)-4-hydroxycoumarin; experimental study].
SALVI F
Riv Anat Patol Oncol; 1954 May; 8(4):569-602. PubMed ID: 13225432
[No Abstract] [Full Text] [Related]
26. [Preparation of 4-hydroxycoumarin ketones with the help of phosphoroxychloride].
KLOSA J
Arch Pharm Ber Dtsch Pharm Ges; 1956 Feb; 289(2):104-10. PubMed ID: 13328064
[No Abstract] [Full Text] [Related]
27. [Clinical observations on the use of 3,3'carboxymethylene bis-(4-hydroxycoumarin) ethyl ester (tromexan) in the treatment of venous thrombosis in obstetrics and gynecology].
SCHIAVINA GP
Minerva Ginecol; 1953 Feb; 5(3):20-1. PubMed ID: 13063225
[No Abstract] [Full Text] [Related]
28. [Independent hypoprothrombinemic action of anticoagulants derived from 4-hydroxycoumarin].
DERECHIN M
Prensa Med Argent; 1956 May; 43(20):1644. PubMed ID: 13370465
[No Abstract] [Full Text] [Related]
29. New anticoagulant for oral use-3-(1'-phenylpropyl)-4 hydroxycoumarin (liquamar); its evaluation for short-term therapy.
GOLD H; LILLEY GW
J Am Med Assoc; 1959 Jul; 170(11):1303-6. PubMed ID: 13664522
[No Abstract] [Full Text] [Related]
30. [Anticoagulant 3-(1-phenyl-propyl)-4-hydroxycoumarin in the treatment of phlebothrombosis and thrombophlebitis].
PERCESEPE E
Rass Int Clin Ter; 1956 Jul; 36(14):419-24. PubMed ID: 13379678
[No Abstract] [Full Text] [Related]
31. [Research on the effect of 4-hydroxycoumarin derivative G 23350 on Shwartzman-Sanarelli phenomenon].
KAISER E; HERBST L
Klin Med Osterr Z Wiss Prakt Med; 1956 Jan; 11(1):33-41. PubMed ID: 13320759
[No Abstract] [Full Text] [Related]
32. Rectal administration of warfarin (coumadin) sodium (sodium [3(2-acetonyl-benzyl)-4 hydroxycoumarin)]).
FREEMAN DJ; MEYER OO
Proc Soc Exp Biol Med; 1956 May; 92(1):52-5. PubMed ID: 13336071
[No Abstract] [Full Text] [Related]
33. Synthesis, antibacterial and antifungal activity of 4-hydroxycoumarin derivatives, analogues of novobiocin.
Patonay T; Litkei G; Bognár R; Erdei J; Miszti C
Pharmazie; 1984 Feb; 39(2):84-91. PubMed ID: 6718480
[TBL] [Abstract][Full Text] [Related]
34. [Effect of 3-(1-phenylpropyl)-4-hydroxycoumarin (marcumar) on the functional, morphological and histochemical characteristics of blood platelets and megakaryocytes; experimental research].
SALVI F; RICCI M
Haematologica; 1955; 39(6):425-40. PubMed ID: 13262650
[No Abstract] [Full Text] [Related]
35. Inhibition of prostaglandin biosynthesis by coumarin, 4-hydroxycoumarin, and 7-hydroxycoumarin.
Lee RE; Bykadi G; Ritschel WA
Arzneimittelforschung; 1981; 31(4):640-2. PubMed ID: 7195710
[TBL] [Abstract][Full Text] [Related]
36. [Inhibition of serum cholinesterase by certain derivatives of 4-hydroxycoumarin].
GROSSMANN V; HAIS IM; KASALICKY B
Cas Lek Cesk; 1950 Apr; 89(17):487-8. PubMed ID: 15414533
[No Abstract] [Full Text] [Related]
37. Synthesis of coumarin derivatives and investigation of their inhibitory effects on lung cancer cell motility.
Zhou R; Yu YH; Kim H; Ha HH
Sci Rep; 2022 Dec; 12(1):21635. PubMed ID: 36517633
[TBL] [Abstract][Full Text] [Related]
38. [Antivitamins K and blood coagulation: a new synthetic anticoagulant, alpha-naphthyl-3-hydroxy-4-coumarin].
MORAUX J
Therapie; 1956; 11(1):104-16. PubMed ID: 13337764
[No Abstract] [Full Text] [Related]
39. Larvicidal activity of 4-hydroxycoumarin derivatives against Aedes aegypti.
Jung JC; Moon HI
Pharm Biol; 2011 Feb; 49(2):190-3. PubMed ID: 21043993
[TBL] [Abstract][Full Text] [Related]
40. The effect of large doses of 1, 3-indandiones and 4-hydroxycoumarins on oxygen consumption of anesthetized cats and rabbits.
SODERBERG U; WACHTMEISTER CA
J Pharmacol Exp Ther; 1956 Jul; 117(3):299-306. PubMed ID: 13332576
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
